Population
Cultured rat aortic smooth muscle cells made quiescent by 48-h exposure to a defined serum-free medium.
Comparison
Angiotensin II added to culture media vs Vehicle or Angiotensin II with saralasin or…
Design
Preclinical
Follow-up
up to 25 hours
Authors
Loading...
Does not yet alter hypertension management; extends experimental evidence for Ang II-driven vascular hypertrophy mechanisms.
Angiotensin II sequentially activates c-myc and PDGF A-chain gene expressions in vascular smooth muscle cells, suggesting a molecular mechanism for angiotensin-induced vascular hypertrophy.
Naftilan et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: